What our pivotal trial actually proved — and the endpoint everyone misreads. The plain-language breakdown clinicians share in their departments.

Medtech and digital health sell on trust, evidence and regulatory credibility — all of which live with the founder. We turn your clinical and regulatory expertise into founder-voice content that earns clinician trust, within the lines, and score the health buyers already in your audience.
We are client zero: our own deep-tech account produced 15,607 engagers → 198 qualified buyers → 370 outreach drafts, automatically. The loop is vertical-agnostic and runs within your compliance lines.
Three leaks that keep the best founders in your space invisible.
Clinicians and health-system buyers trust peers and evidence, not ads. The founder who shares real regulatory and clinical judgment becomes the trusted name — but that judgment stays trapped in your calls.
Health buys crawl through procurement, clinical and compliance gates. Staying credible and top-of-mind across that timeline is a job — and the founders who do it win the contract.
The clinicians and health-system leaders reacting to your posts are your warmest, hardest-to-reach pipeline. Named, scored and approached carefully, they convert. Almost nobody does it.
The kind of founder-voice posts the loop would publish on your account — engineered to earn reach, build trust, and book calls. Engagement figures below are illustrative projections.
What our pivotal trial actually proved — and the endpoint everyone misreads. The plain-language breakdown clinicians share in their departments.

“Your ‘AI-powered’ claim is a MDR liability, not a marketing line.” The founder take that separates the serious players from the vaporware.

A 2-minute clinician-to-clinician walkthrough of the workflow change — the trust-building post that books the health-system call.

Illustrative example posts — the format and caliber we’d craft in your voice. Engagement numbers shown are conservative projections (“est.”), not results from a specific published post. Your real numbers depend on your account, audience and ICP — run the free estimate for a figure grounded in your data.
A deliberately conservative projection of what the loop compounds toward for a founder in your space.
Estimates, not guarantees — modelled conservatively on Alphavant’s own proven track record and typical deep-tech founder accounts. Your real figure depends on your audience, ICP and deal size.
Get my grounded estimate — free →The projections above are modelled on our own proven track record. Across a portfolio of B2B / deep-tech founder accounts, trailing 12 months:
Proven — Alphavant’s own aggregate results (Publer, trailing 365 days). Client names on request, not on a landing page. We ran the loop on ourselves before we sold it.
One closed system on your business — it gets sharper every month. You are not buying posts; you are buying a system we already ran on ourselves.
Answer five questions and get an instant, deliberately-conservative estimate of how many qualified buyers are already in your LinkedIn engagement — and what they’re worth.
Run the free estimate →Yes — claims stay inside what your evidence supports, agreed in writing up front. We amplify your judgment and evidence, we don’t invent claims. Regulatory-safe is a hard guardrail.
We surface your clinical and regulatory language from your own calls and docs, so it passes the peer test — your words, structured for trust and reach.